Nucleoside Analog Antifungal [EPC]

1418 reported adverse events

Drugs of this class: FLUCYTOSINE

These side effects are most commonly reported by patients taking drugs of the Nucleoside Analog Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 467
1 OFF LABEL USE 140
2 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 105
3 MENINGITIS CRYPTOCOCCAL 98
4 ACUTE KIDNEY INJURY 88
5 RENAL IMPAIRMENT 79
6 CONDITION AGGRAVATED 76
7 CRYPTOCOCCOSIS 66
8 DISSEMINATED CRYPTOCOCCOSIS 66
9 DRUG INTERACTION 58
See all common reactions for Nucleoside Analog Antifungal [EPC]

Drugs of the Nucleoside Analog Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPLENIC CANDIDIASIS 4 0.1739
1 NECROTISING FASCIITIS FUNGAL 4 0.1600
2 CEREBRAL VENTRICLE COLLAPSE 8 0.1067
3 ENDOCARDITIS CANDIDA 7 0.0921
4 DISSEMINATED CRYPTOCOCCOSIS 66 0.0872
5 CRYPTOCOCCAL MENINGOENCEPHALITIS 9 0.0687
6 CRYPTOCOCCAL CUTANEOUS INFECTION 11 0.0604
7 MENINGITIS CRYPTOCOCCAL 98 0.0560
8 DISSEMINATED TRICHOSPORONOSIS 4 0.0556
9 PERIHEPATIC ABSCESS 4 0.0482
See all enriched reactions for Nucleoside Analog Antifungal [EPC]